A statistical analysis protocol for the time-differentiated target temperature management after out-of-hospital cardiac arrest (TTH48) clinical trial
Hans Kirkegaard, Asger Roer Pedersen, Ville Pettilä, Jakob Hjort, Bodil Steen Rasmussen, Inge de Haas, Jørgen Feldbæk Nielsen, Susanne Ilkjær, Anne Kaltoft, Anni Nørgaard Jeppesen, Anders Morten Grejs, Christophe Henri Valdemar Duez, Alf Inge Larsen, Valdo Toome, Urmet Arus, Fabio Silvio Taccone, Christian Storm, Timo Laitio, Markus B Skrifvars, Eldar Søreide, Hans Kirkegaard, Asger Roer Pedersen, Ville Pettilä, Jakob Hjort, Bodil Steen Rasmussen, Inge de Haas, Jørgen Feldbæk Nielsen, Susanne Ilkjær, Anne Kaltoft, Anni Nørgaard Jeppesen, Anders Morten Grejs, Christophe Henri Valdemar Duez, Alf Inge Larsen, Valdo Toome, Urmet Arus, Fabio Silvio Taccone, Christian Storm, Timo Laitio, Markus B Skrifvars, Eldar Søreide
Abstract
Background: The TTH48 trial aims to determine whether prolonged duration (48 hours) of targeted temperature management (TTM) at 33 (±1) °C results in better neurological outcomes compared to standard duration (24 hours) after six months in comatose out-of-hospital cardiac arrest (OHCA) patients.
Methods: TTH48 is an investigator-initiated, multicentre, assessor-blinded, randomised, controlled superiority trial of 24 and 48 hours of TTM at 33 (±1) ° C performed in 355 comatose OHCA patients aged 18 to 80 years who were admitted to ten intensive care units (ICUs) in six Northern European countries. The primary outcome of the study is the Cerebral Performance Category (CPC) score observed at six months after cardiac arrest. CPC scores of 1 and 2 are defined as good neurological outcomes, and CPC scores of 3, 4 and 5 are defined as poor neurological outcomes. The secondary outcomes are as follows: mortality within six months after cardiac arrest, CPC at hospital discharge, Glasgow Coma Scale (GCS) score on day 4, length of stay in ICU and at hospital and the presence of any adverse events such as cerebral, circulatory, respiratory, gastrointestinal, renal, metabolic measures, infection or bleeding. With the planned sample size, we have 80% power to detect a 15% improvement in good neurological outcomes at a two-sided statistical significance level of 5%.
Discussion: We present a detailed statistical analysis protocol (SAP) that specifies how primary and secondary outcomes should be evaluated. We also predetermine covariates for adjusted analyses and pre-specify sub-groups for sensitivity analyses. This pre-planned SAP will reduce analysis bias and add validity to the findings of this trial on the effect of length of TTM on important clinical outcomes after cardiac arrest.
Trial registration: ClinicalTrials.gov: NCT01689077 , 17 September 2012.
Keywords: Cardiac arrest; Cerebral performance category; Critical care; Heart arrest; Intensive care; Mortality; Out-of-hospital; Randomised controlled trial; Targeted temperature management.
Figures
References
- Kirkegaard H, Rasmussen B, de Haas I, et al. Time-differentiated target temperature management after out-of-hospital cardiac arrest: a multicenter, randomized, parallel-group, assessor-blinded clinical trial (the TTH48 trial): study protocol for a randomized controlled trial. Trials 2016 doi:10.1186/s13063-016-1338-9
- Dwan K, Gamble C, Williamson PR, et al. Reporting of clinical trials: a review of research funders’ guidelines. Trials. 2008;9:66–77. doi: 10.1186/1745-6215-9-66.
- Finfer S, Bellomo R. Why publish statistical analysis plans? Crit Care Resusc. 2009;11:5–6.
- Hunziker S, Bivens MJ, Cocchi MN, et al. International validation of the out-of-hospital cardiac arrest score in the United States. Crit Care Med. 2011; doi: 10.1097/CCM.0b013e318218a05b
- Adrie C, Cariou A, Mourvillier B, et al. Predicting survival with good neurological recovery at hospital admission after successful resuscitation of out-of-hospital cardiac arrest: the OHCA score. Eur Heart J. 2006;27(23):2840–5. doi: 10.1093/eurheartj/ehl335.
- Oddo M, Ribordy V, Feihl F, Rossetti AO, Schaller MD, Chiolero R, Liaudet L. Early predictors of outcome in comatose survivors of ventricular fibrillation and non-ventricular fibrillation cardiac arrest treated with hypothermia: a prospective study. Crit Care Med. 2008;36:2296–2301. doi: 10.1097/CCM.0b013e3181802599.
- Haugk M, Testori C, Sterz F, Uranitsch M, Holzer M, Behringer W, Herkner H. Relationship between time to target temperature and outcome in patients treated with therapeutic hypothermia after cardiac arrest. Crit Care. 2011;15:R101. doi: 10.1186/cc10116.
- Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–29. doi: 10.1097/00003246-198510000-00009.
- Fergusson D, Aaron SD, Guyatt G, et al. Post-randomisation exclusions: the intention-to-treat principle and excluding patients from analyses. BMJ. 2002;325:652–4. doi: 10.1136/bmj.325.7365.652.
- Ning Y, Sarwat IC, Arnold AM, et al. Results differ by applying distinctive multiple imputation approaches on the longitudinal cardiovascular health study data. Exp Aging Res. 2013;39(1):27–43. doi: 10.1080/0361073X.2013.741968.
- Sterne JAC, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;339:157–60.
- Kahan BC, Morris TP. Reporting and analysis of trials using stratified randomisation in leading medical journals: review and reanalysis. BMJ. 2012;344:e5840. doi: 10.1136/bmj.e5840.
- Schulz KF, Altman DG, Moher D. CONSORT statement: updated guidelines for reporting parallel group randomized trials. BMJ. 2010;340:698–702. doi: 10.1136/bmj.c332.
- Donnino MW, Andersen LW, Berg KM, et al. Temperature management after cardiac arrest an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation and the American Heart Association Emergency Cardiovascular Care Committee and the Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation. Circulation 2015; doi:10.1161/CIR.0000000000000313
Source: PubMed